Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

NCT02231177 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: BI 1744 CL
DRUG: BI 1744 CL/Tiotropium FDC
DRUG: Tiotropium

Sponsor

Boehringer Ingelheim